| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.2B | $1.0B | $0.9B | $0.8B | $0.8B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.1B | $0.2B | $0.2B |
| EPS (Basic) | $2.16 | $1.82 | $1.72 | $1.60 | $1.32 | $0.46 | $0.76 | $0.92 |
| EPS (Diluted) | $2.15 | $1.81 | $1.71 | $1.59 | $1.31 | $0.46 | $0.76 | $0.92 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.1B | $19.3B | $18.9B | $18.6B | $20.8B | $18.8B | $12.6B | $12.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $2.5B | $1.5B | $0.6B | $0.6B |
| Total Liabilities | $17.2B | $17.6B | $17.4B | $17.3B | $18.7B | $16.5B | $10.4B | $10.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.0B | $1.7B | $1.5B | $1.3B | $2.1B | $2.3B | $2.2B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.2B | $0.1B | $-0.1B | $-0.7B | $-1.3B | $-1.2B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.8B | $-0.0B | $-0.1B | $-1.8B | $1.9B | $1.8B | $0.1B | $-0.2B |